Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Regulatory News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.625
Bid: 4.50
Ask: 4.75
Change: -0.475 (-9.74%)
Spread: 0.25 (5.556%)
Open: 4.875
High: 4.40
Low: 4.40
Prev. Close: 4.875
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

29 May 2020 15:02

RNS Number : 4149O
Genedrive PLC
29 May 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

genedrive plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

 

An acquisition or disposal of financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify)iii: Increase in total shares in issue following Placing

x

3. Details of person subject to the notification obligationiv

Name

John Rylands

City and country of registered office (if applicable)

 

4. Full name of shareholder(s) (if different from 3.)v

Name

 

City and country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reachedvi:

28/05/2020

6. Date on which issuer notified (DD/MM/YYYY):

29/05/2020

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

3.76%

 

3.76%

44,870,071

Position of previous notification (if

applicable)

4.83%

 

4.83%

 

       

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

 

1,095,103

591,500

2.44%

1.32%

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. A

1,686,603

3.76%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

 

 

 

 

 

          

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

 

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

 

11. Additional informationxvi

 

     

 

Place of completion

UK Manchester

Date of completion

29/05/2020

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLFLFVVERIAFII
Date   Source Headline
10th Apr 20187:00 amRNSPublication of Genedrive Performance Data in Gut
9th Apr 20189:06 amRNSDirectorate Change
4th Apr 20188:48 amRNSDirector/PDMR Shareholding
3rd Apr 20187:00 amRNSGenedrive® Hepatitis C test in Asia Pacific
27th Mar 20187:00 amRNSgenedrive signs distribution agreement for India
20th Mar 20183:40 pmRNSHolding(s) in Company
20th Mar 20187:00 amRNSInterim Results
13th Mar 20187:00 amRNSCommercial sales of Genedrive® HCV ID Kit begin
27th Feb 20187:00 amRNSgenedrive Receives Funding for TB Test Development
14th Feb 20187:00 amRNSNotice of Results
18th Jan 201811:59 amRNSHardman Res: Hep-C point-of-care test launched
17th Jan 20182:01 pmRNSHolding(s) in Company
17th Jan 20187:00 amRNSTrading update
16th Jan 20187:00 amRNSFirst Successful Field Evaluation of HCV Assay
13th Dec 20177:15 amRNSHardman Research: Remodelled for growth
7th Dec 20174:28 pmRNSDirector/PDMR Shareholding
29th Nov 20172:19 pmRNSResult of AGM
21st Nov 20177:00 amRNSgenedrive plc awarded Innovate UK grant
17th Nov 201711:25 amRNS2017 Annual Report and AGM Notice
14th Nov 20177:00 amRNSDistribution agreement with Sysmex Asia Pacific
8th Nov 20171:31 pmRNSDirectorate Change
6th Nov 20178:51 amRNSHolding(s) in Company
2nd Nov 20177:00 amRNSDistribution update for India
23rd Oct 20177:00 amRNSLaunches Genedrive® Hepatitis C test in Africa
18th Oct 20177:00 amRNSHolding(s) in Company
17th Oct 20177:00 amRNSPreliminary Results
16th Oct 20177:00 amRNSDistribution Agreement
11th Oct 20177:00 amRNSNotice of Preliminary Results
22nd Sep 20179:42 amRNSHolding(s) in Company
11th Sep 20177:00 amRNSGenedrive HCV Kit received CE Marking
27th Jul 20177:00 amRNS$1.4m Funding from US Department of Defense
13th Jul 20177:00 amRNSTrading Update
11th Apr 20177:00 amRNSHep C data presentation at EASL
5th Apr 201712:39 pmRNSDirector/PDMR Shareholding - Replacement
5th Apr 201711:17 amRNSDirector/PDMR Shareholding
30th Mar 20177:00 amRNSInterim Results
27th Mar 20177:00 amRNSHCV Assay submitted for CE IVD Certification
24th Mar 20177:00 amRNSNotice of Interim Results
8th Mar 20177:00 amRNSSuccessful Clinical Results - Genedrive HCV Assay
20th Feb 20177:00 amRNSDirector/PDMR Shareholding
6th Feb 20175:53 pmRNSHoldings in Company
27th Jan 20177:00 amRNSTrading Update
16th Jan 20177:00 amRNSUpdate on US Department of Defense Programme
23rd Dec 201610:48 amRNSDirector/PDMR Shareholding
30th Nov 20162:16 pmRNSResult of AGM
29th Nov 20167:00 amRNSUpdate on CFO Appointment
17th Nov 20167:00 amRNSCE-IVD Certification for Human Genotyping Test
11th Nov 20165:47 pmRNSNotice of AGM
11th Oct 20167:00 amRNSPreliminary Results for the year end 30 June 2016
21st Sep 20167:00 amRNSNotice of Preliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.